Pascal Touchon - 27 Jun 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
27 Jun 2023
Net transactions value
-$23,723
Form type
4
Filing time
29 Jun 2023, 16:15:42 UTC
Previous filing
18 May 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $23,723 -14,291 -2% $1.66 706,671 27 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.